Regulations.gov document
Enzymatic Therapy, Inc. - PredictEase and Predict IB - A combination of probiotics, fiber…
Other · FDA-1997-S-0039 · posted May 25, 2016
Key facts
| Document ID | FDA-1997-S-0039-1881 |
|---|---|
| Title | Enzymatic Therapy, Inc. - PredictEase and Predict IB - A combination of probiotics, fiber, and melatonin help provide comfort that helps your mind de-stress and your body balance for digestion that doesn't offer unwelcome surprise. |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-1997-S-0039 |
| Posted | May 25, 2016 |
| Comment period opens | May 25, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: